Related Experiment Video

Updated: Oct 27, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.0K

Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection

Weronika Bielka1, Agnieszka Przezak1, Andrzej Pawlik1

  • 1Department of Physiology, Pomeranian Medical University in Szczecin, 70-111 Szczecin, Poland.

International Journal of Molecular Sciences
|July 24, 2021
PubMed

Insights

This review explores the complex relationship between type 2 diabetes and COVID-19, highlighting therapeutic challenges and potential drug interactions for better patient management.

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • Pharmacology

Background:

  • COVID-19 presents significant therapeutic challenges, particularly for patients with type 2 diabetes.
  • Pathogenic links include inflammation, glucose dysregulation, hypoxia, immune dysfunction, and renin-angiotensin-aldosterone system (RAAS) activation.
  • Common diabetes medications may impact SARS-CoV-2 infection outcomes, necessitating safety and efficacy evaluations.

Purpose of the Study:

  • To review recent advancements in managing type 2 diabetes in the context of COVID-19.
  • To provide essential clinical recommendations for healthcare providers and patients.

Main Methods:

  • Literature review of current research on COVID-19 and type 2 diabetes.
  • Analysis of potential interactions between diabetes medications and SARS-CoV-2 infection.
  • Synthesis of clinical evidence to formulate recommendations.

Main Results:

  • Identified key pathogenetic links between COVID-19 and type 2 diabetes.
  • Assessed the influence of common diabetes drugs on COVID-19 course.
  • Highlighted the need for tailored therapeutic strategies.

Conclusions:

  • Effective management of type 2 diabetes during COVID-19 requires understanding complex interactions.
  • Clinical recommendations are crucial for optimizing treatment and patient outcomes.
  • Further research is needed to fully elucidate drug efficacy and safety profiles.
Keywords:
COVID-19diabetestherapy

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

908

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
595
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.0K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
12.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
329
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K